Integrin α5β1 mediates attachment, migration, and proliferation in human retinal pigment epithelium: Relevance for proliferative retinal disease

Investigative Ophthalmology and Visual Science

Volumn 50, Issue 12, 2009, Pages 5988-5996

  Li, Rong ^a   Maminishkis, Arvydas ^a   Zahn, Grit ^b   Vossmeyer, Doerte ^b   Miller, Sheldon S ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b Jerini AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [1 ALKYL 5 [(PYRIDINE 2 YLAMINO)METHYL]PYRROLIDIN 3 YLOXY]ACETYLAMINO] 2 (ALKYLAMINO)PROPIONIC ACID; ALPHA5 INTEGRIN; BETA1 INTEGRIN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; F ACTIN; FIBROBLAST GROWTH FACTOR; FIBRONECTIN; LAMININ; PHALLOIDIN; PLATELET DERIVED GROWTH FACTOR BB; PROPIONIC ACID DERIVATIVE; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5; ACTIN; JSM6427; PYRIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE;

ADULT; APICAL MEMBRANE; ARTICLE; AUTOCRINE EFFECT; BASOLATERAL MEMBRANE; CELL ADHESION; CELL CULTURE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; EPITHELIUM CELL; FETUS; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RETINA DISEASE; CELL MEMBRANE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; WOUND HEALING;

ACTINS; CELL ADHESION; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; FIBRONECTINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOBLOTTING; INTEGRIN ALPHA5BETA1; PROPIONIC ACIDS; PYRIDINES; PYRROLIDINES; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; WOUND HEALING;

EID: 73349104950     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3591     Document Type: Article

References (56)

1. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci. 2006;119:3901-3903.
2. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-687.
3. Marmor MF, Wolfensberger TJ, eds. The Retinal Pigment Epithe lium. New York: Oxford University Press; 1998.
4. Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005;85:845-881.
5. McBee JK, Palczewski K, Baehr W, Pepperberg DR. Confronting complexity: the interlink of phototransduction and retinoid metabolism in the vertebrate retina. Prog Retin Eye Res. 2001;20: 469-529.
6. Elner SG, Elner VM. The integrin superfamily and the eye. Invest Ophthalmol Vis Sci. 1996;37:696-701.
7. Anderson DH, Johnson LV, Hageman GS. Vitronectin receptor expression and distribution at the photoreceptor-retinal pigment epithelial interface. J Comp Neurol. 1995;360:1-16.
8. Anderson DH, Guerin CJ, Matsumoto B, Pfeffer BA. Identification and localization of a beta-1 receptor from the integrin family in mammalian retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1990;31:81-93.
9. Chen W, Joos TO, Defoe DM. Evidence for beta 1-integrins on both apical and basal surfaces of Xenopus retinal pigment epithelium. Exp Eye Res. 1997;64:73-84.
10. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes: comparative study of 56 cases. Arch Ophthalmol. 1981;99:1445-1454.
11. Hiscott PS, Grierson I, McLeod D. Retinal pigment epithelial cells in epiretinal membranes: an immunohistochemical study. Br J Ophthalmol. 1984;68:708-715.
12. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
13. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol. 1995;79:953-960.
14. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epireti-nal membranes. Invest Ophthalmol Vis Sci. 1990;31:14-28.
15. Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epireti-nal membrane components with clinical duration of the prolifer-ative tissue. Br J Ophthalmol. 1990;74:393-399.
16. Schwartz D, de la Cruz ZC, Green WR, Michels RG. Proliferative vitreoretinopathy: ultrastructural study of 20 retroretinal membranes removed by vitreous surgery. Retina. 1988;8:275-281.
17. Casaroli Marano RP, Vilaro S. The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci. 1994;35:2791-2803.
18. Serini G, Valdembri D, Bussolino F. Integrins and angiogenesis: a sticky business. Exp Cell Res. 2006;312:651-658.
19. Francis SE, Goh KL, Hodivala-Dilke K, et al. Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol. 2002;22:927-933.
20. George EL, Georges-Labouesse EN, Patel-King RS, Rayburn H, Hynes RO. Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin. Development. 1993;119:1079-1091.
21. Kim S, Bell K, Mousa SA, Varner JA. Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol. 2000;156:1345-1362.
22. Parsons-Wingerter P, Kasman IM, Norberg S, et al. Uniform over-expression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors. Am J Pathol. 2005;167:193-211.
23. Magnussen A, Kasman IM, Norberg S, Baluk P, Murray R, McDonald DM. Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. Cancer Res. 2005;65:2712-2721.
24. Robbins SG, Brem RB, Wilson DJ, et al. Immunolocalization of integrins in proliferative retinal membranes. Invest Ophthalmol Vis Sci. 1994;35:3475-3485.
25. Brem RB, Robbins SG, Wilson DJ, et al. Immunolocalization of integrins in the human retina. Invest Ophthalmol Vis Sci. 1994; 35:3466-3474.
26. Zahn G, Volk K, Lewis GP, et al. Assessment of the integrin α5β1 antagonist JSM6427 in proliferative vitreoretinopathy using in vitro assays and a rabbit model of retinal detachment. Invest Ophthalmol Vis Sci. In press.
27. Stragies R, Osterkamp F, Zischinsky G, et al. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists. J Med Chem. 2007;50:3786-3794.
28. Umeda N, Kachi S, Akiyama H, et al. Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. Mol Pharmacol. 2006;69:1820-1828.
29. Maier AK, Kociok N, Zahn G, et al. Modulation of hypoxia-induced neovascularization by JSM6427, an integrin alpha5beta1 inhibiting molecule. Curr Eye Res. 2007;32:801-812.
30. Farber K, Synowitz M, Zahn G, et al. An alpha5beta1 integrin inhibitor attenuates glioma growth. Mol Cell Neurosci. 2008;39: 579-585.
31. Maminishkis A, Chen S, Jalickee S, et al. Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue. Invest Ophthalmol Vis Sci. 2006;47:3612-3624.
32. Murphy TL, Sakamoto T, Hinton DR, et al. Migration of retinal pigment epithelium cells in vitro is regulated by protein kinase C. Exp Eye Res. 1995;60:683-695
33. Shi G, Maminishkis A, Banzon T, et al. Control of chemokine gradients by the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2008;49:4620-4630.
34. Proulx S, Guerin SL, Salesse C. Effect of quiescence on integrin alpha5beta1 expression in human retinal pigment epithelium. Mol Vis. 2003;9:473-481.
35. Economopoulou M, Hammer J, Wang FE, Fariss R, Maminishkis A, Miller SS. Expression, localization, and function of junctional adhesion molecule-C (JAM-C) in human retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2009;50:1454-1463.
36. Voloboueva LA, Killilea DW, Atamna H, Ames BN. N-tert-butyl hydroxylamine, a mitochondrial antioxidant, protects human retinal pigment epithelial cells from iron overload: relevance to macular degeneration. FASEB J. 2007;21:4077-4086.
37. Li R, Maminishkis A, Wang FE, Miller SS. PDGF-C and -D induced proliferation/migration of human RPE is abolished by inflammatory cytokines. Invest Ophthalmol Vis Sci. 2007;48:5722-5732.
38. Haslam SZ, Woodward TL. Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res. 2001;3:365-372.
39. Zarbin MA. Analysis of retinal pigment epithelium integrin expression and adhesion to aged submacular human Bruch's membrane. Trans Am Ophthalmol Soc. 2003;101:499-520.
40. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci. 1981;21:10-16.
41. Erickson PA, Fisher SK, Anderson DH, Stern WH, Borgula GA. Retinal detachment in the cat: the outer nuclear and outer plexi-form layers. Invest Ophthalmol Vis Sci. 1983;24:927-942.
42. Sarangarajan R, Apte SP. Melanization and phagocytosis: implications for age related macular degeneration. Mol Vis. 2005;11:482-490.
43. Finnemann SC. Role of alphavbeta5 integrin in regulating phagocytosis by the retinal pigment epithelium. Adv Exp Med Biol. 2003;533:337-342.
44. Boyle D, Tien LF, Cooper NG, Shepherd V, McLaughlin BJ. A mannose receptor is involved in retinal phagocytosis. Invest Ophthalmol Vis Sci. 1991;32:1464-1470.
45. Ryeom SW, Sparrow JR, Silverstein RL. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci. 1996;109(part 2):387-395
46. Zhao MW, Jin ML, He S, Spee C, Ryan SJ, Hinton DR. A distinct integrin-mediated phagocytic pathway for extracellular matrix remodeling by RPE cells. Invest Ophthalmol Vis Sci. 1999;40:2713-2723.
47. Ryan SJ. The pathophysiology of proliferative vitreoretinopathy in its management. Am J Ophthalmol. 1985;100:188-193.
48. Campochiaro PA. Pathogenic mechanisms in proliferative vitreo-retinopathy. Arch Ophthalmol. 1997;115:237-241.
49. Esser P, Heimann K, Bartz-Schmidt KU, et al. Apoptosis in prolif-erative vitreoretinal disorders: possible involvement of TGF-beta-induced RPE cell apoptosis. Exp Eye Res. 1997;65:365-378.
50. Miller H, Miller B, Ryan SJ. The role of retinal pigment epithelium in the involution of subretinal neovascularization. Invest Ophthal-mol Vis Sci. 1986;27:1644-1652.
51. Danen EH, Yamada KM. Fibronectin, integrins, and growth control. J Cell Physiol. 2001;189:1-13.
52. Damsky CH, Ilic D. Integrin signaling: it's where the action is. Curr Opin Cell Biol. 2002;14:594-602.
53. Etienne-Manneville S. Actin and microtubules in cell motility: which one is in control? Traffic. 2004;5:470-477.
54. Watanabe T, Noritake J, Kaibuchi K. Regulation of microtubules in cell migration. Trends Cell Biol. 2005;15:76-83.
55. Horwitz A, Duggan K, Buck C, Beckerle MC, Burridge K. Interaction of plasma membrane fibronectin receptor with talin-a trans-membrane linkage. Nature. 1986;320:531-533.
56. Lussier C, Basora N, Bouatrouss Y, Beaulieu JF. Integrins as mediators of epithelial cell-matrix interactions in the human small intestinal mucosa. Microsc Res Tech. 2000;51:169-178.